WHAT THE STUDY ACTUALLY SAYS

The free-radical theory of ageing is elegant. The antioxidant pills failed the test

For 70 years the idea that oxidative damage drives ageing justified a supplement industry. Large randomised trials found antioxidant pills do not extend life, and some raise mortality.

Antioxidant supplements and all-cause mortality (relative risk; 1.0 = no effect)Beta-carotene: 1.05; Vitamin A: 1.07; Vitamin E: 1.03; Vitamin C: 1.02; Selenium: 0.97012Beta-carotene1.05Vitamin A1.07Vitamin E1.03Vitamin C1.02Selenium0.97
Antioxidant supplements and all-cause mortality (relative risk; 1.0 = no effect)
GroupValue (value)
Beta-carotene1.05 (1.01 to 1.09)
Vitamin A1.07 (0.97 to 1.18)
Vitamin E1.03 (1 to 1.05)
Vitamin C1.02 (0.98 to 1.07)
Selenium0.97 (0.91 to 1.03)
Antioxidant supplements and all-cause mortality (relative risk; 1.0 = no effect) Low-risk-of-bias randomised trials in a Cochrane review of 78 trials and 296,707 participants. Values above 1.0 mean more deaths in the supplement group. Source: Cochrane Database of Systematic Reviews

The free-radical theory of ageing holds that reactive oxygen species — the by-products of burning fuel with oxygen — slowly damage cells until the body wears out, and that mopping them up with antioxidants should therefore slow ageing. The theory is 70 years old and intuitively satisfying; the intervention it predicts, antioxidant supplements, has been tested in hundreds of thousands of people and does not extend life, with some antioxidants modestly increasing mortality [s2]. That gap between a clean mechanism and a null trial is one of the most instructive stories in longevity science.

The idea dates to 1956, when Denham Harman proposed that ageing and its diseases stem from "free radical reactions" damaging cell components [s1]. It was a genuinely good hypothesis: oxidative damage to DNA, proteins and lipids does accumulate, and it maps onto much of what goes wrong with age. The problem is not that the chemistry is fake. It is that the causal arrow — damage drives ageing, so blocking damage slows ageing — turned out not to hold when it was tested directly.

What the trials found

The decisive evidence is a Cochrane systematic review of 78 randomised trials in 296,707 participants [s2]. Across all trials, antioxidant supplements had no significant effect on mortality in the more conservative analysis (relative risk 1.02, 95% CI 0.98–1.05) [s2]. But when the reviewers restricted to the 56 trials at low risk of bias — the most trustworthy ones — antioxidant supplements significantly increased mortality (RR 1.04, 95% CI 1.01–1.07) [s2].

Broken out by compound, the same low-bias analysis found beta-carotene raised the risk of death (RR 1.05, 95% CI 1.01–1.09) and vitamin E did too (RR 1.03, 95% CI 1.00–1.05), while the estimates for vitamin A (RR 1.07), vitamin C (RR 1.02) and selenium (RR 0.97) showed no benefit [s2]. The authors' conclusion was blunt: beta-carotene and vitamin E seem to increase mortality, and higher doses of vitamin A may too [s2]. A pill that was supposed to slow the machinery of ageing was, in the best data, nudging the death rate the wrong way.

Why "more antioxidant" can backfire

The mechanistic answer to that paradox is hormesis: a little oxidative stress is a signal the body needs, not just damage to be neutralised. A randomised trial in 39 healthy young men made the point crisply. Exercise improved insulin sensitivity — but only in the men who were not taking antioxidants; supplementing with vitamin C (1000 mg/day) and vitamin E (400 IU/day) abolished that benefit [s3]. The exercise-induced burst of reactive oxygen species was doing useful work, triggering the adaptive response, and the antioxidants blunted it [s3].

The theory has also failed on its own terms in the lab. As a 2009 review pointedly titled "Is the oxidative stress theory of aging dead?" summarised, genetically ramping up or knocking down antioxidant defences in mice has, with few exceptions, not changed how long the animals live [s4]. Some long-lived species carry high levels of oxidative damage; some short-lived ones are well defended. The correlation that launched the theory is real, but it is not the lever it was assumed to be [s4].

What it means

None of this says oxidative biology is unimportant, and it is not a claim about antioxidant-rich foods, which travel with fibre and dozens of other compounds and are not the same thing as isolated high-dose pills. It says the specific promise — that swallowing antioxidants slows ageing — did not survive contact with randomised evidence. The action in the field has since moved to the mitochondria as signalling hubs rather than mere leaky batteries, and to the broader hallmarks-of-ageing framework in which oxidative damage is one interacting process among many, not the master clock.

The pattern here recurs across longevity marketing: a plausible mechanism, an easy pill, and a trial base that either failed or was never run. It is the same shape as the disappointing results for beta-carotene and vitamin A in cancer prevention and for selenium. What to watch is whether interventions that work with oxidative signalling — such as exercise, and the mild stress of a sauna — keep outperforming the pills designed to suppress it.

Sources

Sources

  1. Aging: A Theory Based on Free Radical and Radiation Chemistry — Journal of Gerontology , July 1, 1956
  2. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases — Cochrane Database of Systematic Reviews , March 14, 2012
  3. Antioxidants prevent health-promoting effects of physical exercise in humans — Proceedings of the National Academy of Sciences , May 26, 2009
  4. Is the oxidative stress theory of aging dead? — Biochimica et Biophysica Acta - General Subjects , October 1, 2009
Related coverage